05/16/2017
https://www.congress.gov...
"Mr. Chairman, thank you. I want to thank you and the Ranking Member for the hearing."
"I wanted to ask you, in the context of rare pediatric diseases--I understand that FDA recently awarded the third and final priority review voucher as authorized under FDASIA."
"I appreciate that, and maybe we'll followup with some questions about companies that are interested in seeking a priority review voucher."
"Neither political party has come up with an answer to that central challenge."